Last $6.96 USD
Change Today -0.27 / -3.73%
Volume 692.6K
PGNX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:10 PM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen P. Goff Ph.D.

Scientific Advisor and Chairman of the Virology Scientific Advisory Board, Progenics Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 61 board members in 5 different organizations across 5 different industries.

See Board Relationships
62$119,757

Background*

Dr. Stephen P. Goff, also known as Steve, Ph.D. is an Investigator at Howard Hughes Medical Institute. Dr. Goff has been Scientific Advisor of Progenics Pharmaceuticals Inc. since 1988. He has been the Chairman of Virology Scientific Advisory of Progenics Pharmaceuticals Inc. since April 1991. He has been a Member of Virology Scientific Advisory Board of Progenics Pharmaceuticals Inc. since 1998. He serves as a Member of Scientific Advisory Board of Monogram Biosciences ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

1993-2013
Scientific Advisor and Chairman of the Virology Scientific Advisory Board

Education*

PhD
The Leland Stanford Junior University
BA
Amherst College
Master's Degree
Massachusetts Institute of Technology

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options100,000
Total Number of Options100,000

Total Compensation*

Total Annual Cash Compensation$49,229
Total Calculated Compensation$119,757
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $6.96 USD -0.27

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$852.8K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.